Mikhail Blagosklonny is a scientist, researcher and educator. His areas of specialization are oncology and anti-aging medicine. Blagosklonny is a graduate of First Pavlov State Medical University in St. Petersburg, Russia. There he earned an M.D. in internal medicine as well as a PhD cardiology and experimental medicine. Mikhail Blagosklonny has spent more than two decades doing research on cancer. He is world-renowned for his work on targeted cancer therapies that kill cancerous cells will protecting healthy cells from damage. He is also famed for his work on the mechanisms underlying aging as well as anti-aging drugs. View Mikhail’s profile in LinkedIn
Since graduating from First Pavlov State Medical University, Dr. Blagosklonny has worked at New York Medical College, Valhalla, as an associate professor of medicine. He then went on to work at the Ordway Research Institute in Albany, New York as a senior scientist. In 2009 Dr. Blagosklonny left Ordway Research Institute to take a position at Roswell Park Cancer Institute as a professor of oncology. During his time working as an educator and researcher he has had the opportunity to share groundbreaking information on cancer and aging.
Dr. Mikhail Blagosklonny is well-known in the scientific community for his hypothesis on the possible role TOR signaling may play in aging and cancer. He has proposed helping people extend their lives by treating them with the popular cancer drug rapamycin. Plus he is known for his passionate advocacy of rapamycin to be used in longevity research. The work that Dr. Blagosklonny has done contributed a great deal to the treatment of cancer and helped researchers get a better understanding of age related conditions.
The author of over 270 papers that have been published in peer-reviewed journals, Dr. Blagosklonny’s work has been cited more than 25,000 times. This has given him an 83 h-index. Dr. Blagosklonny is also the editor-in-chief of Oncotarget, Aging and Cell Cycle. He’s Cancer Biology & Therapy’s associate editor and is on Cell Death & Differentiation’s editorial board. The writings of Dr. Mikhail Blagosklonny and the work he has done for publications dealing with cancer and aging has been very valuable.